FDA Challenges Four Rx Ads; TAP Decides To Suspend Prevacid TV Campaign
Executive Summary
TAP's decision to suspend Prevacid TV commercials could be an early indication of a decline in broadcast advertising for pharmaceutical products
You may also be interested in...
Bristol’s DTC Moratorium Will Affect Muraglitazar, Abatacept Launches
Muraglitazar and abatacept are likely to be the first Bristol-Myers Squibb products significantly affected by the company's recent moratorium on direct-to-consumer advertising during a drug's first 12 months on the market
Bristol’s DTC Moratorium Will Affect Muraglitazar, Abatacept Launches
Muraglitazar and abatacept are likely to be the first Bristol-Myers Squibb products significantly affected by the company's recent moratorium on direct-to-consumer advertising during a drug's first 12 months on the market
Pfizer Revises Zoloft Ad After FDA Cites Lack Of Suicide Information
Pfizer is revising Zoloft (sertraline) advertisements after FDA cited the company for not incorporating updated risk information in a print ad for the antidepressant